ALCON
Alcon is a medical device manufacturing company that develops and manufactures innovative medicines and devices to serve the full life cycle of eye care needs. It specializes in the fields of ophthalmology pharmaceuticals and medical devices, eye care, and eye health. The company was founded in 1945 and headquartered in Geneva, Switzerland.
ALCON
Industry:
Health Care Manufacturing Medical Device
Founded:
1945-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.alcon.com
Total Employee:
10001+
Status:
Active
Contact:
+41 62 205 77 00
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Domain Not Resolving Euro IPv6
Similar Organizations
Alcor Scientific
Alcor Scientific is a designer and manufacturer of innovative diagnostic instrumentation and medical devices for the healthcare industry.
DJO Global
DJO Global is a manufacturer and distributor of medical devices for musculoskeletal health, vascular health, and pain management.
GAMA
GAMA is a innovative company specialising in manufacturing and distributing unique, quality products within the healthcare industry.
Inogen
Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy.
SharpXview
SharpXview specializes in the development and production of X-ray imaging and analysis devices for the lower cost to the markets.
SomnoMed
SomnoMed Limited develops, produces, commercializes, and sells devices for the oral treatment of sleep related disorders.
SuperSonic Imagine
SuperSonic Imagine develops and manufactures ultrasound medical imaging systems for evaluating and visualizing tissue elasticity.
WiCare
WiCare develops innovative medical devices that are clinically effective and affordable worldwide.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-08-22 | Aerie Pharmaceuticals | Aerie Pharmaceuticals acquired by Alcon | 770 M USD |
2021-11-08 | Ivantis | Ivantis acquired by Alcon | 475 M USD |
2019-03-18 | PowerVision | PowerVision acquired by Alcon | N/A |
2018-12-19 | Truevision | Truevision acquired by Alcon | N/A |
2018-12-19 | Tear Film Innovations | Tear Film Innovations acquired by Alcon | N/A |
2016-02-18 | Transcend Medical | Transcend Medical acquired by Alcon | N/A |
2014-08-27 | WaveTec Vision | WaveTec Vision acquired by Alcon | N/A |
2010-07-06 | LensX Lasers | LensX Lasers acquired by Alcon | 361.5 M USD |
2009-09-13 | ESBATech | ESBATech acquired by Alcon | 589 M USD |
2007-09-24 | WaveLight | WaveLight acquired by Alcon | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-04-12 | Aurion Biotechnologies | Alcon investment in Venture Round - Aurion Biotechnologies | 120 M USD |
2012-11-20 | SensoMotoric Instruments (SMI) | Alcon investment in Venture Round - SensoMotoric Instruments (SMI) | N/A |
Newest Events participated
Official Site Inspections
http://www.alcon.com Semrush global rank: 77.84 K Semrush visits lastest month: 1.38 M
- Host name: 104.18.26.249
- IP address: 104.18.26.249
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Alcon"
Org Chart Alcon - The Official Board
Sep 27, 2024 The organizational chart of Alcon displays its 51 main executives including David Endicott, Timothy Stonesifer and Jeannette Bankes. Toggle navigation The Official Board. โฆSee details»
Home | Alcon.ca
Alcon.ca is the world's largest eye care device company, providing surgical and vision care products.See details»
Alcon - Governance - Leadership Team
Contact Alcon Investor Relations +41 589 112 110 +1 817 615 2789 [email protected]. Computershare. Switzerland: +41 62 205 77 00 U.S. Toll Free: +1 800 736 3001 International: +1 781 575 3100. Quick Links. โฆSee details»
Alcon - Wikipedia
Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a sโฆSee details»
Alcon: Developing Innovative Eye Care Treatments
PRECISION7 ® is available in the U.S. only. References: 1. In a 2-week prospective clinical study in the US; n=181; CLEAR CARE ® Cleaning & Disinfecting Solution used for cleaning and โฆSee details»
About Alcon | Alcon.ca
Alcon is the largest eye care device company in the world. We operate in the ophthalmic surgical and vision care markets, which are large, dynamic and growing. We are dedicated to helping people see brilliantly. We have a strong โฆSee details»
Governance - Alcon
Contact Alcon Investor Relations +41 589 112 110 +1 817 615 2789 [email protected]. Computershare. Switzerland: +41 62 205 77 00 U.S. Toll Free: โฆSee details»
Alcon - Crunchbase Company Profile & Funding
Alcon Intelligent Services: This service provides digital solutions to enhance connectivity and access for eye care professionals, aiming to meet customer demands and patient needs. Alcon Research Institute: The institute supports โฆSee details»
Social Impact and Sustainability - Alcon.ca
Brilliant Lives. Alcon is working toward a world where treatable, preventable conditions affecting eye health receive the attention they need. More than 1.1 billion people are living with uncorrected vision impairment โ 90% of whom โฆSee details»
Alcon - LinkedIn
Alcon | 661,318 followers on LinkedIn. Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to ...See details»
Corporate Giving | Alcon
Alconโs Corporate Giving efforts help people around the world by increasing access to quality eye care, driving eye care provider training and skills-transfer, and strengthening communities. ...See details»
Alcon - Governance - Executive Committee
Contact Alcon Investor Relations +41 589 112 110 +1 817 615 2789 [email protected]. Computershare. Switzerland: +41 62 205 77 00 U.S. Toll Free: โฆSee details»
David J. Endicott - CEO at Alcon - The Org
David J. Endicott is the CEO of Alcon, a member of its Board of Directors, and leads the Alcon Executive Committee. He joined Alcon in July of 2016 as Chief Operating Officer. Prior to โฆSee details»
Corporate Responsibility - Alcon.ca
Alcon donates ophthalmic medicines and devices to local eye care clinics who work to improve and restore vision to patients around the world. Our donations help improve the sustainability โฆSee details»
Home | in.alcon.com
Alcon Medical Information and Product Complaints. To report a concern about the quality of an Alcon product, or to report an adverse event: Email: [email protected] Telephone: +91 80-4544 โฆSee details»
Innovative Eye Care Products & Solutions | Alcon
In 1981, Alcon set out to help support research in eye health and to expand the frontiers of vision sciences globally โ from this concept Alcon Research Institute (ARI) was born. Since then, the โฆSee details»
Reasons to Retain Alcon Stock in Your Portfolio for Now
4 days ago Alcon Inc.โs ALC growth in the third quarter of 2024 is driven by its robust Surgical business. The performance of the Vision Care arm also appears encouraging. The โฆSee details»
About Alcon - uk.Alcon.com
Alcon is the largest eye care device company in the world. We operate in the ophthalmic surgical and vision care markets, which are large, dynamic and growing. We are dedicated to helping โฆSee details»
Alcon Marketing Strategy: Building Eye Care Excellence
Nov 24, 2024 Alconโs marketing summary highlights a company that is strategically positioned for growth and enduring success in the eye care industry. With over one billion people โฆSee details»
Social Impact and Sustainability | Alcon
Social Impact Goals. By 2025, Alconโs philanthropic support and training programs will help improve vision for 5 million people afflicted with untreated cataracts in low- and middle-income โฆSee details»